Bathi sadurunge mbayar bunga, pajak, lan amortisasi: eternatx.com (ERNA)

Tandha merek eternatx.com (ERNA)

Eterna Therapeutics (ERNA) implements gene editing and mRNA methods to combat hematological tumors. Monitoring of EBITDA_Co demonstrates financial stability, with the indicator currently at 0.00. Development relies on Tox-T patents and licensing agreements. The project's success is based on the efficiency of cellular reprogramming combined with strict control of laboratory costs and sufficient liquidity reserves.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi Eterna Therapeutics Inc. (ERNA): kanggo periode 23.11.2025 - 12.11.2026

Eterna Therapeutics Inc. (ERNA) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
Bagan rega Eterna Therapeutics, Inc.|ERNA - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Nilai pasar Eterna Therapeutics|ERNA - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Aset Bersih saben Saham Eterna Therapeutics|ERNA - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku eternatx.com|ERNA - Total Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Rasio Utang marang Ekuitas Eterna Therapeutics|ERNA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Eterna Therapeutics, Inc.|ERNA - Gunggung utang perusahaan|Utang marang modal buku Eterna Therapeutics|ERNA - Utang jangka dawa perusahaan|Utang jangka cendhak Eterna Therapeutics|Rasio jangkoan perantara eternatx.com
- rincian bathi lan kelipatan pasar:
ERNA - Bathi resik perusahaan|Prakiraan bathi resik Eterna Therapeutics|ERNA - Pangali P/E|Pangali Forward P/E Eterna Therapeutics, Inc.|ERNA - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Eterna Therapeutics|ERNA - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Eterna Therapeutics|ERNA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan eternatx.com|ERNA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Eterna Therapeutics
Pambiji fundamental perusahaan:Eterna Therapeutics ERNA
Barang unggulan eternatx.com

Absolute operating profit measures the cash flow from core operations before interest and taxes, determining the internal efficiency of the business and its capacity for self-financing. For Eterna Therapeutics (ERNA), this operating profit summary reflects the capital's resilience to logistical disruptions and sanction restrictions within the clinical research sector, where any decline in this indicator signals a critical risk of funding shortfalls.

Karo sapa Eterna Therapeutics saingan

TG Pharma - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ACLX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IRON: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Syndax Pharmaceuticals, Inc. (SNDX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Kura Oncology Inc (KURA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ADC Therapeutics Corp|Bathi sadurunge bunga, pajak, lan amortisasi Foghorn FHTX|Bathi operasional EBITDA VOR|nkartatx.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA COEP (Coeptis Therapeutics, Inc.)|Actinium Pharma (ATNM) - Bathi sadurunge bunga, pajak, lan amortisasi|ESLA: Bathi operasional sadurunge ngurangi amortisasi|CASI Pharmaceuticals - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MRKR: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi in8bio.com (INAB)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi GT Biopharma|APTO: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Bio-Path (BPTH)|MEI Pharma Corporation - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA VINC (Vincerx Pharma)